PubMed ID:
30275282
Public Release Type:
Journal
Publication Year: 2018
Affiliation: Department of Pediatrics, University of Virginia, Charlottesville, VA deboer@virginia.edu.; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.
DOI:
https://doi.org/10.2337/dc18-1079
Authors:
DeBoer Mark D., Filipp Stephanie L., Gurka Matthew J.
Request IDs:
21779
Studies:
Diabetes Prevention Program Outcomes Study
We assessed whether changes in metabolic syndrome (MetS) severity during the treatment of prediabetes are associated with reduced risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD).